Skip to content
Search

Latest Stories

New report reveals significant awarding and attainment gaps for Black trainees in pharmacy education

New report reveals significant awarding and attainment gaps for Black trainees in pharmacy education

This persisting issue leads to the profession losing talented potential pharmacists from underrepresented and diverse backgrounds, says BPSA President 

The Royal Pharmaceutical Society (RPS) has called for action on differential degree awarding and registration assessment attainment gaps for Black trainees in initial pharmacy education and training.


According to a new report published by the RPS on Tuesday (6 February), there’s a pharmacy degree awarding gap of 12 per cent and a registration assessment attainment gap of 22.6 per cent between Black and White trainees.

The variation in pharmacy attainment for Black trainees was first recorded by the General Pharmaceutical Council (GPhC) in 2013, and the Pharmaceutical Journal has been tracking the awarding gap at undergraduate level.

Even after a decade, significant differences exist in the awarding and attainment gaps for Black students and trainees compared to their White counterparts, the report said.

Amandeep Doll, RPS Head of Professional Belonging and Engagement and lead author of the report, commented: “The gaps that persist are inequitable and deeply disappointing, with real world impacts on individuals and their careers.”

“This report is a call to action for the entire pharmacy community to prioritise the reduction of degree awarding and registration differential attainment gaps and provide greater equity for Black trainees.”

She reiterated that RPS and its partner organisations are committed to addressing this issue.

“By working together, and implementing the recommendations of the report, we can make a real difference and create a more inclusive and diverse pharmacy profession which ultimately benefits patient care,” she added.

To create the report, the RPS collaborated with several other stakeholders including the British Pharmaceutical Students' Association (BPSA), the Black Pharmacists Collective, the Black Pharmacist Initiative, the General Pharmaceutical Council (GPhC), NHS England Chief Pharmaceutical Officer’s Team and the Pharmacy Schools Council.

BPSA President Nonyelum Anigbo expressed concern that the differential attainment gap continues to hold back many Black trainee pharmacists from becoming qualified, leading to the profession losing “talented potential pharmacists” from underrepresented and diverse backgrounds.

“Equitable changes need to be made to ensure Black pharmacy students and trainees are given opportunities and support to reach their full potential and successfully join the pharmacy workforce,” she said.

To tackle the gap, the report recommended that data collection and analysis should be improved and role models should be promoted.

Additionally, it suggested removing bias from processes and providing support during the transition from pharmacy student to foundation training placements.

Furthermore, the report emphasised the importance of educational supervisor training, the implementation of protected learning time in foundation trainee placements, and an annual equality, diversity and inclusion forum to ensure good practice is being shared across Schools of Pharmacy and training placements.

As informed by the RPS, smaller task and finish groups will be created to act on the recommendations, and there will be a working group meeting every six months to update on actions.

Addressing the differential attainment gap is also one of the top priorities for NHS England’s Inclusive Pharmacy Practice Programme, which is supported by RPS, APTUK and 13 other national partner organisations.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less